HYDROCHLOROTHIAZIDE

Product NDC
70518-2666
11-digit product format
705182666
Labeler code
70518
Product ID
70518-2666_dc88f8e4-1d16-f204-e053-2a95a90ad6b3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
HYDROCHLOROTHIAZIDE
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA040702
Marketing category
ANDA
Marketing start
2020-03-31
Marketing end
0000-00-00
Substance
HYDROCHLOROTHIAZIDE
Active strength
13 mg/1
Pharmacologic classes
Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-2666HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.]11Legacy NDC20250327_1da05129-2d1d-462b-a64f-2c82fac735f9.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2666-07051826660030 TABLET in 1 BLISTER PACK (70518-2666-0) 30 tablet2020-03-310000-00-00NoNoCurrent
70518-2666-17051826660190 TABLET in 1 BOTTLE, PLASTIC (70518-2666-1) 90 tablet2021-07-270000-00-00NoNoCurrent